Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2000
10/19/2000WO2000061162A1 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa
10/19/2000WO2000061153A1 Medicinal compositions and their method of preparation
10/19/2000WO2000061095A1 Use of a synergistic mixture of polyphenols and vitamin compounds in cosmetic and dermatological compositions and methods for capturing free radicals on the skin and skin appendices
10/19/2000WO2000061078A2 Sunscreen agents containing hydroxycarboxylic acid alkyl- and/or -alkenyloligoglycoside esters
10/19/2000WO2000061077A1 Liquid dispersion polymer compositions, their preparation and their use
10/19/2000WO2000041505A3 Anthranilic acid derivatives
10/19/2000WO2000033787A3 Deodorant cosmetic composition
10/19/2000WO2000023022A8 Method and compositions for in situ formation of protective and/or medicated films on body tissue
10/19/2000WO2000012720A8 Elongase genes and uses thereof
10/19/2000WO2000009070A3 Inhibition of pathogenic processes related to tissue trauma
10/19/2000DE19917505A1 Treating cytokine-mediated diseases, e.g. asthma, allergy, eczema, rheumatoid arthritis or transplant rejection, using new or known maduraphthalazine derivatives
10/19/2000DE19916837A1 New di- or tetrahydro-benzoazulene derivatives, are integrin inhibitors useful e.g. for treating thrombosis, coronary heart disease, arteriosclerosis, tumors, osteoporosis or rheumatoid arthritis
10/19/2000DE19916208A1 Sonnenschutzmittel Sunscreens
10/19/2000DE19915602A1 3-Amino-4-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung 3-amino-4-arylpropan-1-ol-derivatives, their preparation and use
10/19/2000DE19915601A1 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung 3-amino-3-arylpropan-1-ol-derivatives, their preparation and use
10/19/2000DE19915057A1 Monoklonale Antikörper gegen das humane Mcm3 Protein, Verfahren zu ihrer Herstellung und ihre Verwendung Monoclonal antibodies to human protein Mcm3, processes for their preparation and their use
10/19/2000CA2372028A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/19/2000CA2371223A1 49 human secreted proteins
10/19/2000CA2371172A1 50 human secreted proteins
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2370523A1 49 human secreted proteins
10/19/2000CA2370425A1 Pharmaceutical compounds
10/19/2000CA2369981A1 Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same
10/19/2000CA2369728A1 Substituted bicyclic heteroaryl compounds as integrin antagonists
10/19/2000CA2369619A1 Caspase inhibitors and the use thereof
10/19/2000CA2369454A1 Uses of mammalian ox2 protein and related reagents
10/19/2000CA2369381A1 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa
10/19/2000CA2369378A1 Low-molecular inhibitors of complement proteases
10/19/2000CA2369272A1 Medicinal compositions and their method of preparation
10/19/2000CA2368049A1 Integrin receptor ligands
10/19/2000CA2365945A1 Products and methods for treating ptp lar related diseases
10/19/2000CA2365918A1 49 human secreted proteins
10/19/2000CA2365917A1 Bone morphogenic proteins
10/19/2000CA2365913A1 Tumor necrosis factor receptor homologs and nucleic acids encoding the same
10/19/2000CA2365910A1 Human proteins and polynucleotides encoding them
10/19/2000CA2365905A1 48 human secreted proteins
10/19/2000CA2365623A1 Tyrosine kinase substrate (tks) proteins
10/19/2000CA2364556A1 Liquid dispersion polymer compositions, their preparation and their use
10/19/2000CA2356128A1 Method of providing cosmetic/medical therapy
10/19/2000CA2305942A1 Composition containing at least one aromatic bicyclic compound and at least one 2-alkyl alcan-1-ol or an ester, and its uses
10/19/2000CA2269364A1 Treatment of inflammatory and allergic disorders
10/18/2000EP1044967A2 2-Pyridinylguanidine urokinase inhibitors
10/18/2000EP1044966A1 (Poly)thia-alkyne compounds and their derivatives, compositions containing them and their use
10/18/2000EP1044676A2 Oily material composition
10/18/2000EP1044273A2 COMPOSITIONS DERIVED FROM $i(MYCOBACTERIUM VACCAE) AND METHODS FOR THEIR USE
10/18/2000EP1044217A2 Sag: sensitive to apoptosis gene
10/18/2000EP1044215A1 Anti-inflammatory phenylalanine derivatives
10/18/2000EP1044001A1 Integrin receptor antagonists
10/18/2000EP0706368B1 Anti-acne composition containing a poria cocos wolf extract
10/18/2000CN1270525A Use of physiologically acceptable vanadium compounds salts and compelxes
10/18/2000CN1270513A Use of at least an extract of the genus chrysanthemum for stimulating skin and/or hair pigmentation
10/18/2000CN1270509A Resorcinol derivatives
10/18/2000CN1270163A 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
10/18/2000CN1270162A 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
10/18/2000CN1270057A Medical wine and ointment for treating bone fracture and injury
10/18/2000CN1270027A Stable aqueous solution of phthalylglutamic acidimide derivative
10/18/2000CN1270019A Nano-size emulsion containing alkoxyalkenyl or glucose alkoxyalkenyl succinate and uses in cosmetics and pharmaceutics
10/18/2000CN1057467C Medicine for treating impetigo
10/18/2000CN1057463C Pus drawing-out ointment
10/18/2000CN1057461C Natural freckle-diminishing face-beautifying product and preparation method thereof
10/18/2000CN1057449C Tincture skin diseases
10/17/2000US6133479 Phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions
10/17/2000US6133463 For use in cosmetic and dermatological compositions for treating or caring for the skin
10/17/2000US6133440 Extract includes acetylated polysaccharide having average molecular weight of 70 to 80 kilodaltons and composed of d-galactose, d-glucose, and d-mannose having primarily beta-1,4 linkages; wound healing agents
10/17/2000US6133326 Compositions and methods for decreasing sebum production
10/17/2000US6133319 For treating an interleukin-8 (il-8) mediated disease by administering a phenyl urea or phenyl thiourea of given formula, such as n-cyclohexyl-n'-(2-hydroxy-4-nitrophenyl)urea
10/17/2000US6133309 Treatment of T-helper cell type 2-mediated immune disease by retinoid antagonists
10/17/2000US6133268 1,4-disubstituted piperazines
10/17/2000US6133264 Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation
10/17/2000US6133257 Fused polycyclic 2-aminopyrimidine derivatives
10/17/2000US6133250 Oral 1α-hydroxyprevitamin D in methods for increasing blood level of activated vitamin D
10/17/2000US6133240 Tetrahydronapthalene derivatives and their therapeutic use
10/17/2000US6132759 Medicaments containing gelatin cross-linked with oxidized polysaccharides
10/17/2000US6132740 Resorcinol derivatives
10/17/2000US6131226 1,4-dihydropyridine compounds as bradykinin antagonists
10/17/2000CA2305893A1 Use of maduraphthalazine derivatives as inhibitors of proinflammatory cytokines
10/17/2000CA2192944C Stimulation of hair growth by peptide-copper complexes
10/17/2000CA2116743C Swellable wound dressing materials
10/13/2000CA2305047A1 2-pyridinylguanidine urokinase inhibitors
10/12/2000WO2000060082A2 Vesicle associated proteins
10/12/2000WO2000060080A2 Molecules of the immune system
10/12/2000WO2000059943A2 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE
10/12/2000WO2000059941A1 Purposeful movement of human migratory cells away from an agent source
10/12/2000WO2000059940A2 Platelet-derived growth factor related gene and protein
10/12/2000WO2000059939A1 COMPOUNDS AND METHODS FOR STIMULATING β-CATENIN MEDIATED GENE EXPRESSION AND DIFFERENTIATION
10/12/2000WO2000059904A2 Compounds and methods to treat cardiac failure and other disorders
10/12/2000WO2000059901A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000WO2000059874A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO2000059873A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
10/12/2000WO2000059866A1 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof
10/12/2000WO2000059864A1 Lta4 hydrolase inhibitors
10/12/2000WO2000059520A1 Herbal compositions and uses for the treatment of allergic reactions
10/12/2000WO2000059513A1 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1α, 25-DIHYDROXY VITAMIN D¿3?
10/12/2000WO2000059509A1 Phthalazine derivatives for treating inflammatory diseases
10/12/2000WO2000059503A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059502A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059484A2 Use of arylalkanoylpyridazines
10/12/2000WO2000059465A1 Cosmetic or dermopharmaceutical compositions containing plant extracts of pinus lambertania to counteract all types of dryness of the skin
10/12/2000WO2000059462A1 Composition for cosmetic and dermatological skin care
10/12/2000WO2000059448A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
1 ... 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 ... 1065